Cookies
Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

CNL Financial Group —An Industry Leader

Headquartered in Orlando Florida, CNL Financial Group (CNL) is a leading private investment management firm providing global real estate and alternative investments. Throughout its history, CNL has focused on underserved, undercapitalized markets and has extensive experience investing in and managing REITs in the healthcare, office, retail, lifestyle, restaurant, hotel and multifamily development sectors. CNL developed its contrarian investment philosophy from its experience investing in real estate through various market cycles.

Since its inception in 1973, CNL and/or its affiliates have:

  • Formed or acquired companies with more than $36 billion in assets.
  • Distributed 9 non-traded REITs, 7 of which have gone full cycle.
  • Invested approximately $8.5 billion in seniors housing and healthcare.
  • Successfully launched 2 seniors housing and healthcare non-traded REITs.

Learn more about the REIT’s experienced Management Team.

As of March 31, 2025. Data derived from market value of liquidated assets and assets still held by CNL and/or its affiliates. The prior performance of real estate programs sponsored by CNL may not be indicative of the future results of CNL Healthcare Properties. Prior programs sponsored by CNL have been adversely affected by general economic conditions and other external factors during their respective operating periods. The information herein does not supplement or revise any information in the company’s public filings. To the extent information herein conflicts with the filings, the filings shall govern.